These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23564221)

  • 1. Transjugular intrahepatic portosystemic shunt induced short- and long-term cerebral blood flow variations in cirrhotic patients: an arterial spin labeling MRI study.
    Zheng G; Zhang LJ; Cao Y; Pan Z; Qi RF; Ni L; Shi D; Fan X; Lu GM
    Metab Brain Dis; 2013 Sep; 28(3):463-71. PubMed ID: 23564221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
    Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
    Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cerebral blood flow after transjugular intrahepatic portosystemic shunt can help predict the development of hepatic encephalopathy: an arterial spin labeling MR study.
    Zheng G; Zhang LJ; Wang Z; Qi RF; Shi D; Wang L; Fan X; Lu GM
    Eur J Radiol; 2012 Dec; 81(12):3851-6. PubMed ID: 22832118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain regional homogeneity changes following transjugular intrahepatic portosystemic shunt in cirrhotic patients support cerebral adaptability theory--a resting-state functional MRI study.
    Ni L; Qi R; Zhang LJ; Zhong J; Zheng G; Wu X; Fan X; Lu GM
    Eur J Radiol; 2014 Mar; 83(3):578-83. PubMed ID: 24299611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic changes of intrinsic brain activity in cirrhotic patients after transjugular intrahepatic portosystemic shunt: a resting-state FMRI study.
    Qi R; Zhang LJ; Zhong J; Wu S; Zhang Z; Zhong Y; Ni L; Zheng G; Jiao Q; Wu X; Fan X; Liu Y; Lu G
    PLoS One; 2012; 7(10):e46681. PubMed ID: 23056400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
    Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
    Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transjugular intrahepatic portosystemic shunt does not alter cerebral blood flow.
    Iversen P; Keiding S; Mouridsen K; Ott P; Vilstrup H
    Clin Gastroenterol Hepatol; 2011 Nov; 9(11):1001-3. PubMed ID: 21806953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhotic patients with a transjugular intrahepatic portosystemic shunt undergoing major extrahepatic surgery.
    Kim JJ; Dasika NL; Yu E; Fontana RJ
    J Clin Gastroenterol; 2009 Jul; 43(6):574-9. PubMed ID: 19169145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diastolic dysfunction on echocardiography does not predict survival after transjugular intrahepatic portosystemic stent-shunt in patients with cirrhosis.
    Armstrong MJ; Gohar F; Dhaliwal A; Nightingale P; Baker G; Greaves D; Mangat K; Zia Z; Karkhanis S; Olliff S; Mehrzad H; Steeds RP; Tripathi D
    Aliment Pharmacol Ther; 2019 Mar; 49(6):797-806. PubMed ID: 30773660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between pre-TIPS hepatic hemodynamics and postoperative incidence of hepatic encephalopathy.
    Deng D; Liao MS; Qin JP; Li XA
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):232-6. PubMed ID: 16698582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MELD score is better than Child-Pugh score in predicting 3-month survival of patients undergoing transjugular intrahepatic portosystemic shunt.
    Salerno F; Merli M; Cazzaniga M; Valeriano V; Rossi P; Lovaria A; Meregaglia D; Nicolini A; Lubatti L; Riggio O
    J Hepatol; 2002 Apr; 36(4):494-500. PubMed ID: 11943420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study.
    Zhang LJ; Qi R; Zhong J; Xu Q; Zheng G; Lu GM
    PLoS One; 2012; 7(8):e42824. PubMed ID: 22912746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.
    Zheng G; Lu H; Yu W; Luo S; Liu Y; Liu W; Liu H; Wu L; Zheng L; Kong X; Zhang LJ; Lu GM
    Eur Radiol; 2017 Nov; 27(11):4699-4709. PubMed ID: 28523351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
    Wang Z; Wu YF; Yue ZD; Zhao HW; Wang L; Fan ZH; Zhang Y; Liu FQ
    World J Gastroenterol; 2021 Feb; 27(5):416-427. PubMed ID: 33584073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between pre-TIPS liver perfusion by the portal vein and the incidence of post-TIPS chronic hepatic encephalopathy.
    Hassoun Z; Deschênes M; Lafortune M; Dufresne MP; Perreault P; Lepanto L; Gianfelice D; Bui B; Pomier-Layrargues G
    Am J Gastroenterol; 2001 Apr; 96(4):1205-9. PubMed ID: 11316171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt.
    Rabie RN; Cazzaniga M; Salerno F; Wong F
    Am J Gastroenterol; 2009 Oct; 104(10):2458-66. PubMed ID: 19532126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].
    Liu MH; Zhou F; Wang XB; Chen LP; Li GZ; Zhao Q
    Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):596-600. PubMed ID: 30317791
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic perfusion before and after the transjugular intrahepatic portosystemic shunt procedure: impact on survival.
    Walser EM; DeLa Pena R; Villanueva-Meyer J; Ozkan O; Soloway R
    J Vasc Interv Radiol; 2000; 11(7):913-8. PubMed ID: 10928532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term clinical outcomes in patients with viral hepatitis related liver cirrhosis after transjugular intrahepatic portosystemic shunt treatment.
    Teng D; Zuo H; Liu L; Dong J; Ding L
    Virol J; 2018 Oct; 15(1):151. PubMed ID: 30285813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.